Phenylephrine gel - SLA Pharma
Alternative Names: Incostop; SLV-325; VEN 308Latest Information Update: 09 Oct 2021
At a glance
- Originator SLA Pharma
- Developer Assembly Biosciences; SLA Pharma
- Class Antihypotensives; Decongestants; Ethanolamines; Mydriatics; Phenethylamines; Skin disorder therapies; Small molecules; Urologics
- Mechanism of Action Alpha adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Faecal incontinence
Most Recent Events
- 29 Jul 2016 Discontinued - Phase-I for Faecal Incontinence in Europe (Rectal)
- 27 Jul 2016 No recent reports on development identified - Phase-II for Faecal Incontinence in North America (Rectal)
- 11 Jul 2014 Ventrus Biosciences has merged with Assembly Pharmaceuticals to form Assembly Biosciences